Literature DB >> 12119547

Lactate, glucose and energy metabolism in the ischemic brain (Review).

Avital Schurr1.   

Abstract

For many decades, lactate was considered to be an end product of anaerobic glycolysis in mammalian tissues with no other function in metabolism. As determination of lactate level became a routine in hospital blood work, fluctuations in its levels were associated with situations other than oxygen lack. It was just a matter of time before elevated lactate blood levels emerged as a 'red flag' for potential malaise and frequently was blamed as the of it. Lactate and its accompanying acidosis are still considered today to be major contributors to selective neuronal damage in cerebral ischemia despite the emergence of alternative, more compelling postulates as to the causes of this damage. The attitude, especially among clinicians, has been difficult to change despite recent findings that strongly indicate lactate to be a possible beneficial intermediate in brain energy metabolism. This review revisits briefly the annals that brought about the lingering negative attitude toward lactate and expands on the more recent findings and debates that have illuminated this monocarboxylate in a different, more positive light.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119547

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  39 in total

1.  Modulation of acid-sensing ion channels: molecular mechanisms and therapeutic potential.

Authors:  Xiang-Ping Chu; Christopher J Papasian; John Q Wang; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-18

Review 2.  Aquaporins in the brain: from aqueduct to "multi-duct".

Authors:  Jérôme Badaut; Jean-François Brunet; Luca Regli
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

3.  Hypertonic lactate solutions: a new horizon for fluid resuscitation?

Authors:  Florian Wagner; Peter Radermacher; Hiroshi Morimatsu
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

4.  Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients.

Authors:  Carole Ichai; Guy Armando; Jean-Christophe Orban; Frederic Berthier; Laurent Rami; Corine Samat-Long; Dominique Grimaud; Xavier Leverve
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

5.  Inhibition of G protein-coupled receptor 81 (GPR81) protects against ischemic brain injury.

Authors:  Zhe Shen; Lei Jiang; Yang Yuan; Tian Deng; Yan-Rong Zheng; Yan-Yan Zhao; Wen-Lu Li; Jia-Ying Wu; Jian-Qing Gao; Wei-Wei Hu; Xiang-Nan Zhang; Zhong Chen
Journal:  CNS Neurosci Ther       Date:  2014-12-11       Impact factor: 5.243

Review 6.  Acid-sensing ion channels in pathological conditions.

Authors:  Xiang-Ping Chu; Zhi-Gang Xiong
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting.

Authors:  Xavier M Leverve; Cindy Boon; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Iqbal Mustafa
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

Review 8.  Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?

Authors:  Tiandong Leng; Yejie Shi; Zhi-Gang Xiong; Dandan Sun
Journal:  Prog Neurobiol       Date:  2014-01-24       Impact factor: 11.685

9.  Ischemia as a possible effect of increased intra-abdominal pressure on central nervous system cytokines, lactate and perfusion pressures.

Authors:  Athanasios Marinis; Eriphili Argyra; Pavlos Lykoudis; Paraskevas Brestas; Kassiani Theodoraki; Georgios Polymeneas; Efstathios Boviatsis; Dionysios Voros
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

10.  Aquaporin and blood brain barrier.

Authors:  Francesca Bonomini; Bonomini Francesca; Rita Rezzani
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.